z-logo
open-access-imgOpen Access
Repression of BK Virus Infection of Human Renal Proximal Tubular Epithelial Cells by Pravastatin
Author(s) -
Takahito Moriyama,
Andrey Sorokin
Publication year - 2008
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e31816c4ec5
Subject(s) - pravastatin , bk virus , internalization , endocytosis , biology , virology , immunology , kidney , kidney transplantation , endocrinology , cell , cholesterol , genetics
BK virus (BKV), a human polyomavirus, causes BKV nephritis, which often leads to graft loss after renal transplantation. Currently, the only efficient therapy against BKV nephritis seems to be a reduction or change of immunosuppressive agents, but this may increase the inherent risk of rejection. Here, we report the ability of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitor (statin), which is routinely used to treat hypercholesterolemia, to repress BKV entry pathways in human renal proximal tubular epithelial cells (HRPTEC) and, correspondently, prevent BKV infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here